Partner Highlight: Heal Mary

How we optimize patient success with Heal Mary's clinical trial platform

CTOAM Partner Highlight: Heal Mary

What is Heal Mary?

Heal Mary Logo

Heal Mary is an online service that helps patients, advocates and caregivers to find and access the right clinical trial for them. This groundbreaking app is improving patient access to treatments and raising awareness of the incredible benefits that clinical trials can provide for cancer patients.

Heal Mary was founded by Cassandra Hui, whose personal story is inspiring. When Cassandra’s mom was diagnosed with stage 4 breast cancer, Cassandra did everything she could to find help. But it wasn’t long before she was confronted with the giant gap between what standard care in Canada could offer her mother and what was actually available through clinical trials.

This fuelled Cassandra, out of her own need and frustration, to start an organization that could help connect cancer patients with the right clinical trial – easily, efficiently, and for free. She named the organization “Heal Mary”, after her beloved mother. (Happily, her mom went on to survive stage 4 cancer!)

How CTOAM works with Heal Mary

Cancer Treatment Options and Management (CTOAM) and Heal Mary share similar missions: we are both dedicated to educating patients about what is possible with the newest medical science and cancer treatments; and helping patients and caregivers to gain access to these treatments as fast as possible, with as little cost as possible.

CTOAM connects many of our patients with Heal Mary’s resources, especially if they are looking to pursue clinical trials on their own. If our team of experts has determined that a clinical trial will benefit a patient, using Heal Mary is a typical next step if the client would like to gain access to the trial on their own. It is fast and simple to complete the required applications and the Heal Mary team helps to expedite your approvals and support you through every step of the process.

Watch our Video Interview

Interview with Heal Mary’s Cassandra Hui and CTOAM’s Michelle Morand

CTOAM’s co-founder and Precision Cancer Medicine Advocate, Michelle Morand, talks with Heal Mary founder, Cassandra Hui. They discuss what motivated Cassandra to start Heal Mary, the challenges of being a cancer patient and a caregiver, and how clinical trials can save lives. And, of course, they share tips on how to find and access the right clinical trials for you!

Learn more about clinical trials

Learn more about Heal Mary

Discover How CTOAM and Heal Mary Can Help You

If you’d like to find out how to access the very best treatments and diagnostics for your cancer care, as fast as possible, reach out today.

Have questions? Email us anytime.

Please note: CTOAM does not earn any commission from any person, company, or organization that we promote, work with, partner with, or recommend to our patients and clients. Any recommendations we make are completely non-biased and entirely evidence-based. This has been our policy from day one, and will remain as such.

CTOAM is a Canadian-based personalized cancer research and advocacy service that connects cancer patients and their oncologists with the newest advancements in personalized cancer care and precision oncology. We serve patients and doctors worldwide.

Get Your Questions Answered!

Discover how you can get better cancer treatment

Book a free 30-min Cancer Care Strategy Session

"I can’t tell you how much your support means to me. My call today with you was invaluable. You came into our lives at the perfect time. It’s rare to just be able to talk without a sales pitch. I could tell that my needs were more important." - Diane

Discover how you can get better cancer treatment! Get your questions answered now

Book a free 30-min Cancer Care Strategy Session

Sign Up for Our Newsletter

Get the latest advancements in cancer care delivered straight to your inbox each month!

Beat cancer faster and prevent cancer recurrence

Discover the newest, leading-edge advancements in cancer care...

Read our research blog

We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. More info. That's Fine